ALK-Vac Anti-Tumor Resistance Vaccine Shows Promise in ALK+ NSCLC

Cancer Therapy Advisor·May 31

This story is reported by Cancer Therapy Advisor. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Essential Oils Show Promise for Some Symptoms of Infusion-Based Cancer Treatments

Oncology Nurse Advisor·Jul 15

2

Stage 4 ALK-Positive NSCLC Survival Is Nearly 7 Years

Pulmonology Advisor·Jan 17

3

Strict School Vaccine Mandates Work, New Research Shows

Clinical Advisor·Dec 8

4

Oral Mezigdomide Regimen Looks Promising for R/R Multiple Myeloma

Oncology Nurse Advisor·Mar 10

5

How Effective is Clofazimine in Treating Multidrug-Resistant Tuberculosis?

Pulmonology Advisor·Aug 30

6

Rapidly growing tumor on the forearm

Clinical Advisor·Apr 14

7

Mechanisms of Drug Resistance in Acute Myeloid Leukemia

Oncology Nurse Advisor·Apr 19

8

Derm Dx: Tumor of the zygomatic region

Clinical Advisor·Jan 28